MEDVF (Medivolve) Cyclically Adjusted PB Ratio: (As of Jul. 25, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Medivolve Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Medivolve  (OTCPK:MEDVF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Medivolve Cyclically Adjusted PB Ratio Related Terms


Medivolve Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Medivolve's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medivolve Cyclically Adjusted PB Ratio Chart

Medivolve Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.19 0.72 0.22 0.05 0.01

Medivolve Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.03 0.02 0.01 0.00

MEDVF vs DMTKQ, TMO, DHR: Cyclically Adjusted PB Ratio Comparison

For the Diagnostics & Research subindustry, Medivolve's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medivolve Cyclically Adjusted PB Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Medivolve's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Medivolve's Cyclically Adjusted PB Ratio falls into.



Medivolve Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Medivolve's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Medivolve's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.462/126.2576*126.2576
=-0.462

Current CPI (Mar. 2024) = 126.2576.

Medivolve Quarterly Data

Book Value per Share CPI Adj_Book
201406 6.926 99.473 8.791
201409 6.114 99.394 7.766
201412 1.193 98.367 1.531
201503 0.613 99.789 0.776
201506 0.247 100.500 0.310
201509 -0.234 100.421 -0.294
201512 -0.803 99.947 -1.014
201603 -0.450 101.054 -0.562
201606 -0.562 102.002 -0.696
201609 0.695 101.765 0.862
201612 0.687 101.449 0.855
201703 0.577 102.634 0.710
201706 0.479 103.029 0.587
201709 0.425 103.345 0.519
201712 1.806 103.345 2.206
201803 1.731 105.004 2.081
201806 1.670 105.557 1.998
201809 1.581 105.636 1.890
201812 1.484 105.399 1.778
201903 1.344 106.979 1.586
201906 1.084 107.690 1.271
201909 0.830 107.611 0.974
201912 0.661 107.769 0.774
202003 0.630 107.927 0.737
202006 1.051 108.401 1.224
202009 1.203 108.164 1.404
202012 -0.783 108.559 -0.911
202103 -0.170 110.298 -0.195
202106 -0.540 111.720 -0.610
202109 0.289 112.905 0.323
202112 0.515 113.774 0.572
202203 0.468 117.646 0.502
202206 0.311 120.806 0.325
202209 0.134 120.648 0.140
202212 0.009 120.964 0.009
202303 -0.066 122.702 -0.068
202306 -0.116 124.203 -0.118
202309 -0.209 125.230 -0.211
202312 -0.435 125.072 -0.439
202403 -0.462 126.258 -0.462

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Medivolve Business Description

Address 198 Davenport Road, Toronto, ON, CAN, M5R 1J2
Medivolve Inc is a healthcare technology and services company. It is engaged in finding and developing disruptive technologies, groundbreaking innovations, and partnerships to help combat COVID-19 and transform human health management. The company operated one reportable segment, the COVID Testing facilities across the United States Of America.